Understanding how nanoscale bone composition affects osteoporosis
Multifactorial contribution of bone nanoscale composition to tissue quality in osteoporosis
This study is looking at how the tiny structure of bone affects its strength in people with osteoporosis, and by providing bone samples, you can help us find better ways to diagnose and treat this condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Trustees of the Stevens Institute of Technology NIH-funded |
| Lab location | 1 site (Hoboken, United States) |
| Project ID | NIH-11212348 on NIH RePORTER |
What this research studies
This research investigates the relationship between the nanoscale composition of bone and its quality in patients with osteoporosis. By analyzing the tiny building blocks of bone, the study aims to uncover how these factors contribute to bone strength and fragility. The approach involves advanced techniques to assess the nanoscale properties of bone tissue, which could lead to better diagnostic and treatment strategies for osteoporosis. Patients may be involved in providing bone samples for analysis, helping to advance our understanding of this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with osteoporosis or those at high risk for developing the condition.
Not a fit: Patients with conditions unrelated to bone health or those who do not have osteoporosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for diagnosing and treating osteoporosis, ultimately reducing the risk of fractures.
How similar studies have performed: While there has been research on bone composition, this study's focus on nanoscale properties is relatively novel and has not been extensively tested.
Where this research is happening
Hoboken, United States
- The Trustees of the Stevens Institute of Technology — Hoboken, United States (Active)
Researchers
- Principal investigator: Querido, William — The Trustees of the Stevens Institute of Technology
- Study coordinator: Querido, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.